Cancer nanomedicine for combination cancer immunotherapy
By Jutaek Nam, S. Son, Kyung Soo Park, W. Zou, L. Shea, J. Moon. Nature Reviews Materials, 2019
774 citations recorded by the source corpus.
Subfields: Biomedical Engineering, Immunology, Oncology
View Paper: https://www.semanticscholar.org/paper/c7d7a40869e5dd29df608de549c67c7c32844fae
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yajun Wang
- T. Gong
- Yongliang Cao
- Yongkai Cao
- Dahua Fan
- Meiqun Cao
Citations in the corpus
- Nanomedicine in cancer therapy (2023, methodology): “In recent years, a series of small molecules including folic acid, biotin, and ACUPA ( S , S -2-[3-[5-amino-1-carboxypentyl]-ureido]-pentanedioic acid) have also been used as targeting ligands for tumor-selective delivery of nanomedicines.”